Moreover, knocking down PES1 increased the sensitivity of pancreatic cancer cells to BET inhibitors, AKT inhibitors and mTOR pathway inhibitors, and decreased the mRNA and protein levels of c-Myc, which is related to the sensitivity of pancreatic cancer cells to BET inhibitors. The gene discussed is PES1; the disease is pancreatic neoplasm.